PPARGC1A and endothelial dysfunction: Administration of MitoQ to elderly mice with primary aging-related endothelial dysfunction improves endothelial function and increases mitochondrial levels of PGC1a\mtSOD and COX-IV, while also reducing susceptibility to mitochondrial damage 141.